Anoopum Gupta, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Ataxia | 6 | 2023 | 145 | 2.800 |
Why?
|
| Ataxia Telangiectasia | 5 | 2023 | 107 | 2.800 |
Why?
|
| Ataxia | 10 | 2023 | 304 | 1.820 |
Why?
|
| Parkinsonian Disorders | 2 | 2021 | 272 | 1.200 |
Why?
|
| Dysarthria | 1 | 2023 | 57 | 0.890 |
Why?
|
| Pursuit, Smooth | 1 | 2020 | 41 | 0.770 |
Why?
|
| Cerebellar Diseases | 1 | 2022 | 222 | 0.750 |
Why?
|
| Parkinson Disease | 3 | 2022 | 2774 | 0.670 |
Why?
|
| Eye Movements | 2 | 2023 | 506 | 0.630 |
Why?
|
| Paresis | 1 | 2015 | 179 | 0.480 |
Why?
|
| Aphasia | 1 | 2015 | 179 | 0.480 |
Why?
|
| Neurology | 1 | 2022 | 762 | 0.460 |
Why?
|
| Cerebellum | 1 | 2020 | 1490 | 0.450 |
Why?
|
| Maze Learning | 2 | 2012 | 478 | 0.450 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 1421 | 0.430 |
Why?
|
| Muscle Weakness | 1 | 2015 | 414 | 0.430 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2022 | 88 | 0.390 |
Why?
|
| Theta Rhythm | 1 | 2012 | 207 | 0.370 |
Why?
|
| Spatial Behavior | 1 | 2010 | 90 | 0.360 |
Why?
|
| Hippocampus | 2 | 2012 | 3661 | 0.330 |
Why?
|
| Disease Progression | 4 | 2023 | 13256 | 0.320 |
Why?
|
| Movement | 2 | 2022 | 1470 | 0.250 |
Why?
|
| Ankle | 2 | 2023 | 327 | 0.230 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2023 | 43 | 0.220 |
Why?
|
| Friedreich Ataxia | 1 | 2023 | 76 | 0.210 |
Why?
|
| Gait | 3 | 2022 | 784 | 0.200 |
Why?
|
| Behavior, Animal | 1 | 2010 | 1882 | 0.200 |
Why?
|
| Multiple System Atrophy | 1 | 2022 | 122 | 0.190 |
Why?
|
| Hepatic Encephalopathy | 1 | 2021 | 139 | 0.180 |
Why?
|
| Wrist | 1 | 2022 | 225 | 0.180 |
Why?
|
| Speech Disorders | 1 | 2021 | 189 | 0.180 |
Why?
|
| Memory | 1 | 2010 | 2163 | 0.180 |
Why?
|
| Neurofilament Proteins | 1 | 2021 | 318 | 0.170 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 19862 | 0.170 |
Why?
|
| Motor Neurons | 1 | 2023 | 851 | 0.160 |
Why?
|
| Headache | 2 | 2016 | 1219 | 0.160 |
Why?
|
| Uncertainty | 1 | 2023 | 725 | 0.160 |
Why?
|
| Computers | 1 | 2019 | 611 | 0.150 |
Why?
|
| Methylphenidate | 1 | 2020 | 473 | 0.140 |
Why?
|
| Speech | 1 | 2021 | 540 | 0.140 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2016 | 51 | 0.140 |
Why?
|
| Lethargy | 1 | 2015 | 39 | 0.130 |
Why?
|
| Diplopia | 1 | 2016 | 199 | 0.130 |
Why?
|
| Lower Extremity | 1 | 2023 | 1151 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2022 | 40955 | 0.130 |
Why?
|
| Humans | 21 | 2023 | 742088 | 0.120 |
Why?
|
| Child | 5 | 2023 | 77478 | 0.120 |
Why?
|
| Rats, Inbred BN | 1 | 2012 | 235 | 0.110 |
Why?
|
| Young Adult | 5 | 2022 | 56350 | 0.100 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 862 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1728 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13019 | 0.100 |
Why?
|
| Motor Activity | 1 | 2021 | 2714 | 0.100 |
Why?
|
| Brain | 2 | 2022 | 26343 | 0.090 |
Why?
|
| Adolescent | 4 | 2022 | 85649 | 0.090 |
Why?
|
| Leukemia | 1 | 2015 | 1507 | 0.070 |
Why?
|
| Adult | 7 | 2022 | 213712 | 0.070 |
Why?
|
| Rats | 2 | 2012 | 24265 | 0.060 |
Why?
|
| Male | 9 | 2021 | 349538 | 0.060 |
Why?
|
| Action Potentials | 1 | 2010 | 1814 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 12730 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2010 | 1771 | 0.050 |
Why?
|
| Receptors, GABA | 1 | 2022 | 288 | 0.050 |
Why?
|
| Intermediate Filaments | 1 | 2021 | 175 | 0.050 |
Why?
|
| Aged | 4 | 2021 | 162944 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2022 | 648 | 0.040 |
Why?
|
| Postural Balance | 1 | 2021 | 620 | 0.040 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 724 | 0.030 |
Why?
|
| Decision Making | 1 | 2010 | 3869 | 0.030 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2015 | 64 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2015 | 6587 | 0.030 |
Why?
|
| Piracetam | 1 | 2015 | 87 | 0.030 |
Why?
|
| Female | 4 | 2021 | 379592 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57683 | 0.030 |
Why?
|
| Middle Aged | 4 | 2021 | 213127 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2015 | 160 | 0.030 |
Why?
|
| Animals | 3 | 2022 | 168561 | 0.030 |
Why?
|
| Craniotomy | 1 | 2015 | 729 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5062 | 0.020 |
Why?
|
| Neurons | 1 | 2010 | 9325 | 0.020 |
Why?
|
| Fever | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 1835 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2015 | 1949 | 0.020 |
Why?
|
| Genotype | 1 | 2023 | 12946 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8297 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 1509 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9941 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12958 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40450 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20086 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 35342 | 0.000 |
Why?
|